Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Wan-li Chen"'
Autor:
Po-Lan Su, Jung-Yueh Chen, Chang-Yao Chu, Yi-Lin Chen, Wan-Li Chen, Kuan-Yu Lin, Chung-Liang Ho, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Yi-Lin Wu, Yau-Lin Tseng, Chao-Chun Chang, Yi-Ting Yen, Chia-Ying Lin, Chien-Chung Lin, Wu-Chou Su
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Neoadjuvant immunotherapy and chemotherapy have improved the major pathological response (MPR) in patients with early-stage operable non-small cell lung cancer (NSCLC). This study aimed to assess whether the presence of targetable driver mut
Externí odkaz:
https://doaj.org/article/249de0c14737440c9d0617b01e951b12
Autor:
Wenya Huang, Chung-Liang Ho, Chung-Ta Lee, Wan-Li Chen, Shu-Ching Yang, Nan-Haw Chow, Yi-Lin Chen
Publikováno v:
PLoS ONE, Vol 18, Iss 4 (2023)
Microsatellite instability (MSI) is the primary predictive biomarker for therapeutic efficacies of cancer immunotherapies. Establishment of the MSI detection methods with high sensitivity and accessibility is important. Because MSI is mainly caused b
Externí odkaz:
https://doaj.org/article/2c4c51d996cd443ab7889acbb3dda7a4
Autor:
Yi-Lin Chen, Chung-Liang Ho, Chen-Yan Hung, Wan-Li Chen, Chen Chang, Yi-Hsin Hou, Jian-Rong Chen, Pin-Jun Chen, Nan-Haw Chow, Wenya Huang, Ya-Ting Hsu, Tsai-Yun Chen, Tsunglin Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Clonality assessment, which can detect neoplastic T cells by identifying the uniquely recombined T-cell receptor (TCR) genes, provides important support in the diagnosis of T-cell lymphoma (TCL). BIOMED-2 is the gold standard clonality assay and has
Externí odkaz:
https://doaj.org/article/7be49aa75398497dad4bbbabdf9a2e0d
Autor:
Ruo-Yu Hu, Jing-Ya Wang, Wan-Li Chen, Jie Zhao, Chun-Hai Shao, Ji-Wei Wang, Xiao-Min Wei, Jin-Ming Yu
Publikováno v:
BMC Psychology, Vol 9, Iss 1, Pp 1-12 (2021)
Abstract Background Breast cancer is a common tumor in China and has become a public health problem in modern society. Stress plays an important role in the occurrence and progression of cancer. At present, the current situation of stress on breast c
Externí odkaz:
https://doaj.org/article/dc243ab8f8414c0aa0e1e896a05d1a21
Autor:
Po-Lan Su, MD, Chien-Yu Lin, MD, Yi-Lin Chen, MS, Wan-Li Chen, MS, Chien-Chung Lin, MD, PhD, Wu-Chou Su, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 8, Pp 100202- (2021)
Targeted therapy with combined dabrafenib and trametinib has been proven to provide clinical benefits in patients with NSCLC with a BRAF V600E mutation. Nevertheless, the treatment strategy for patients with NSCLC with BRAF non-V600E mutations remain
Externí odkaz:
https://doaj.org/article/4a4e4b0cf770465bbd8130347adaee9e
Autor:
Wan-Li Chen, Cheng-Gang Zhang, Zi-Yi Cui, Jing-Ya Wang, Jie Zhao, Ji-Wei Wang, Xian Wang, Jin-Ming Yu
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Physical activity and good nutrition are important behavioral factors in promoting health and preventing disease. It is important to understand the factors affecting physical activity and nutrition. The purpose of this study was t
Externí odkaz:
https://doaj.org/article/b272d493979c4e11a6f3563ab1b88929
Autor:
Yi-Lin Chen, Wan-Li Chen, Yi-Chia Cheng, Ming-Ching Lin, Shu-Ching Yang, Hung-Wen Tsai, Chien-Chung Lin, Wu-Chou Su, Nan-Haw Chow, Chung-Liang Ho
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257152 (2021)
Approximately 5-7% of non-small cell lung cancer (NSCLC) cases harbor an anaplastic lymphoma kinase (ALK) fusion gene and may benefit from ALK inhibitor therapy. To detect ALK fusion genes, we developed a novel test using reverse transcription polyme
Externí odkaz:
https://doaj.org/article/f237227974f540cd9dec0686f2f84839
Publikováno v:
Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-7 (2018)
Abstract Background Stomach cancer survivors (SCS) often carry the dual burden of the cancer itself and other comorbidities; meanwhile, they are highly motivated to seek health advice about lifestyles to improve their health and quality of life (QOL)
Externí odkaz:
https://doaj.org/article/7f9f16d986fc425bb84d23e115fafc02
Autor:
Yi-Lin Chen, Chien-Chung Lin, Shu-Ching Yang, Wan-Li Chen, Jian-Rong Chen, Yi-Hsin Hou, Cheng-Chan Lu, Nan-Haw Chow, Wu-Chou Su, Chung-Liang Ho
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Third-generation tyrosine kinase inhibitors (TKIs) were developed to overcome T790M-mediated resistance to earlier generations of epidermal growth factor receptor (EGFR)-targeted TKIs. We compared four well-established and one in-house method for the
Externí odkaz:
https://doaj.org/article/4d445a92355640e0a8207cd5b957c13c
Publikováno v:
ARKIVOC, Vol 2012, Iss 6, Pp 16-25 (2011)
Externí odkaz:
https://doaj.org/article/ecfda8505e7148e3925843373f490db9